These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2190394)

  • 41. [Immunosuppression and the problems in homologous bone marrow transplantation].
    Yabe H; Kato S
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):681-2. PubMed ID: 8963784
    [No Abstract]   [Full Text] [Related]  

  • 42. Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation.
    Hiraoka A; Ohashi Y; Okamoto S; Moriyama Y; Nagao T; Kodera Y; Kanamaru A; Dohy H; Masaoka T;
    Bone Marrow Transplant; 2001 Jul; 28(2):181-5. PubMed ID: 11509936
    [TBL] [Abstract][Full Text] [Related]  

  • 43. French multicentre study: comparison of two specific and four nonspecific methods for Sandimmune (cyclosporine) blood and plasma (separated at 37 degrees C or at 22 degrees C) monitoring.
    Vernillet L; Humbert H; Aupetit B; Berard M; Bertault-Peres P; Billaud E; Bizollon CA; Breteau M; Brisson AM; Codet JP
    Transplant Proc; 1990 Jun; 22(3):1218-23. PubMed ID: 2190383
    [No Abstract]   [Full Text] [Related]  

  • 44. Cyclosporine does not prevent in vivo expression of T cell activation antigens following allogeneic bone marrow transplantation.
    Forman SJ; Gallagher MT; Zaia JA; Wright C; Blume KG
    Transplantation; 1984 Feb; 37(2):219-20. PubMed ID: 6420961
    [No Abstract]   [Full Text] [Related]  

  • 45. [Anatomo-clinical presentation of graft-versus-host disease treated with cyclosporin A].
    Al Rustom K; Pierard-Franchimont C; Pierard GE
    Dermatologica; 1985; 171(2):65-71. PubMed ID: 3899758
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A prospective randomized study of acute graft-v-host disease in 107 patients with leukemia: methotrexate/prednisone v cyclosporine A/prednisone.
    Forman SJ; Blume KG; Krance RA; Miner PJ; Metter GE; Hill LR; O'Donnell MR; Nademanee AP; Snyder DS
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2605-7. PubMed ID: 3079090
    [No Abstract]   [Full Text] [Related]  

  • 47. Re: Twenty-year follow-up in patients with aplastic anemia given marrow grafts from HLA-identical siblings and randomized to receive methotrexate/cyclosporine or methotrexate alone for prevention of graft-versus-host disease.
    Sorror ML; Leisenring W; Deeg HJ; Martin PJ; Storb R
    Biol Blood Marrow Transplant; 2005 Jul; 11(7):567-8. PubMed ID: 15983557
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of posttransplant cyclosporine treatment on the development of syngeneic GVHD in recipients of UV-B irradiated bone marrow cells.
    Ohajekwe OA; Hardy MA; Oluwole SF
    Transplant Proc; 1995 Feb; 27(1):1385. PubMed ID: 7878922
    [No Abstract]   [Full Text] [Related]  

  • 49. Bone marrow transplantation for severe aplastic anemia. Effect of a preparative regimen of cyclophosphamide-low-dose total-lymphoid irradiation and posttransplant cyclosporine-methotrexate therapy.
    Champlin RE; Ho WG; Nimer SD; Gajewski JG; Selch M; Burnison M; Holley G; Yam P; Petz L; Winston DJ
    Transplantation; 1990 Apr; 49(4):720-4. PubMed ID: 2326866
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of leukemia by marrow transplantation from HLA incompatible donors. Effect of HLA-disparity on GVHD, relapse and survival.
    Hansen JA; Anasetti C; Beatty PG; Martin PJ; Sanders JE; Storb R; Thomas ED
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():108-11. PubMed ID: 2390636
    [No Abstract]   [Full Text] [Related]  

  • 51. Transplantation of T cell-depleted bone marrow in histoincompatible rabbits: improved engraftment and long-term chimeras after the addition of irradiated donor buffy coat cells and irradiated autologous cryopreserved bone marrow.
    Gratwohl A; Baldomero H; Nissen C; Speck B
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2756-7. PubMed ID: 3274587
    [No Abstract]   [Full Text] [Related]  

  • 52. [Acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation].
    Kai S; Shinohara Y; Ifuku H; Ohe Y; Misawa M; Noguchi K; Kohsaki M; Kanamaru A; Hara H; Nagai K
    Rinsho Ketsueki; 1985 Jan; 26(1):20-7. PubMed ID: 3889401
    [No Abstract]   [Full Text] [Related]  

  • 53. Bone marrow transplantation and graft-versus-host disease.
    Powles RL
    Curr Opin Immunol; 1989-1990; 2(6):870-5. PubMed ID: 2486567
    [No Abstract]   [Full Text] [Related]  

  • 54. Prevention of graft-versus-host disease after bone marrow and small bowel transplantation by ultraviolet B modulation of bone marrow cells.
    Chowdhury NC; Jin MX; Hardy MA; Oluwole SF
    Transplant Proc; 1993 Feb; 25(1 Pt 1):475-6. PubMed ID: 8438384
    [No Abstract]   [Full Text] [Related]  

  • 55. Is cyclosporine blood concentration monitoring necessary in patients treated for severe chronic plaque form psoriasis?
    Lindholm A; Zachariae H; Reitamo S; Ibsen HH; Oxholm A; Reunala T; Jansén C
    Transplant Proc; 1990 Jun; 22(3):1293-5. PubMed ID: 2190392
    [No Abstract]   [Full Text] [Related]  

  • 56. Influence of infusion duration on the efficacy and toxicity of intravenous cyclosporine in bone marrow transplant patients.
    McGuire TR; Tallman MS; Yee GC; Nemunaitis JJ; Higano CS; McGuffin RW; Singer JW
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):501-4. PubMed ID: 3291288
    [No Abstract]   [Full Text] [Related]  

  • 57. Cyclosporine in allogeneic bone marrow transplantation.
    Ringdén O
    Transplantation; 1986 Nov; 42(5):445-52. PubMed ID: 3538528
    [No Abstract]   [Full Text] [Related]  

  • 58. Immune mechanisms in cyclosporine-induced syngeneic graft-versus-host disease.
    Hess AD; Fischer AC
    Transplantation; 1989 Dec; 48(6):895-900. PubMed ID: 2688206
    [No Abstract]   [Full Text] [Related]  

  • 59. Long-term cyclosporin therapy may decrease the risk of chronic graft-versus-host disease.
    Lönnqvist B; Aschan J; Ljungman P; Ringdén O
    Br J Haematol; 1990 Apr; 74(4):547-8. PubMed ID: 2346739
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment with continuous high-dose intravenous cyclosporine following clinical intestinal transplantation.
    Grant D; Sommerauer J; Mimeault R; Garcia B; Ghent C; Zhong R; Stiller C; Duff J
    Transplantation; 1989 Jul; 48(1):151-2. PubMed ID: 2749888
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.